Silverman Joshua
CIK 0001524858
Interim CEO, Interim PresidentDirector
Filings
32
Latest May 19, 2026
Issuers covered
6
Showing
32 of 32
Page 1
Track record
3 of 6 open-market trades scored (50% price coverage) - 3 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 0% | -9.1% | -9.3% | -7.2% | -10.7% |
| 90 days | 3 | 0% | -11.2% | -8.4% | -7.2% | -17.9% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Silverman Joshua has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals, Inc. | 8 | Jan 2, 2026 |
| SNPX | Synaptogenix, Inc. | 7 | May 19, 2026 |
| AYRO | Ayro, Inc. | 6 | Oct 31, 2025 |
| FEMY | Femasys Inc | 4 | Mar 18, 2026 |
| MYMD | Mymd Pharmaceuticals, Inc. | 4 | Apr 15, 2026 |
| PMCB | Pharmacyte Biotech, Inc. | 3 | Jan 7, 2026 |
All filings
32 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|